权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

NIAID TETRAMER FACILITY

NIAID 四聚体设施

基本信息

批准号：
8357391
负责人：
John David Altman
金额：
$ 7.43万
依托单位：
EMORY UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-08-01 至 2012-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8357391
关键词：
Acquired Immunodeficiency Syndrome Alleles Animals Australia Autoimmunity Basic Science Canada Centers for Disease Control and Prevention (U.S.)Clinical Clinical Research Communicable Diseases Communities Contracts Department of Defense Doctor of Philosophy Europe Foundations Funding Grant Human Immune response Institutes Israel Malignant Neoplasms Methodology Mus National Center for Research Resources National Institute of Allergy and Infectious Disease Nonprofit Organizations Organ Transplantation Primates Principal Investigator Production Qualifying Quality Control Reagent Research Research Infrastructure Research Personnel Research Support Resources Source Specimen T-Lymphocyte United States Food and Drug Administration United States National Institutes of Health Universities Virginia cost design disorder prevention nonhuman primate pre-clinical research programs repository vaccine evaluation

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. The National Institute of Allergy and Infectious Diseases (NIAID) supports reagent programs and repositories that provide centralized resources for the research community. These facilities support research by providing reliable sources of quality assured materials, specimens, or experimental animals at reasonable cost to qualified investigators. The NIAID Tetramer Facility, established at Emory University in 1998 under the direction of John Altman, Ph.D., serves the scientific community as a centralized source of quality-controlled tetramer reagents for basic, preclinical, and clinical research. The NIAID Division of AIDS oversees the Facility, which is contracted by the AIDS Research and Reference Reagent Program with subcontracts to McKesson BioServices and Virginia Mason. The Facility has provided tetramer reagents, comprising human, murine, and non-human primate MHC alleles to researchers at non-profit organizations both in the U.S. and abroad, including investigators supported by ten NIH Institutes, the Food and Drug Administration, the Department of Defense, the Centers for Disease Control and Prevention, and private non-profit U.S. foundations, as well as to researchers in Europe, Australia, Israel, and Canada; has produced tetramers applicable to a wide range of T cell studies, including research on AIDS and other infectious diseases, cancer, organ transplantation, autoimmunity, clinical vaccine evaluation, and basic studies on T cells and immune responses; and has developed standardized methodology for tetramer usage and evaluated new advances in tetramer design and production to assure that the Facility's reagents reflect state-of-the-art capabilities.

这个子项目是利用这些资源的众多研究子项目之一